Medis ehf.

A company with extensive experience in generic pharmaceuticals, Medis offers a wide portfolio of products and intellectual property to other pharmaceutical companies. With a proven track record in securing regulatory approval prior to patent expiries, we have obtained marketing authorisations in nearly 40 countries to date and export to most of the European Union. Established in 1985, Medis draws on the development and manufacturing capabilities of its parent company, the Actavis Group. Medis handles sales of products and intellectual property in the form of registration dossiers for the Group. Our pharmaceutical knowledge and expertise have contributed significantly to the Actavis Group抯 expansion in international markets. In turn, the combined strengths of companies within the Group enable Medis to extend its portfolio and improve its services still further.